targeted tolerogenic Synthetic Vaccine Particle (t²SVP™) products are designed to induce an antigen-specific immune tolerance. The t²SVP™ products 'instruct' the immune system to prevent and suppress pro-inflammatory responses against the antigen presented in the vaccine, thereby enabling the desired immune system modulation without causing global immune suppression. Applications include autoimmune diseases, allergies, and transplant rejection.